Compare ALEMBIC LTD with VENUS REMEDIES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs VENUS REMEDIES - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD VENUS REMEDIES ALEMBIC LTD/
VENUS REMEDIES
 
P/E (TTM) x 74.6 -1.1 - View Chart
P/BV x 2.6 0.1 3,529.5% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ALEMBIC LTD   VENUS REMEDIES
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
VENUS REMEDIES
Mar-18
ALEMBIC LTD/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs72126 57.2%   
Low Rs3461 55.5%   
Sales per share (Unadj.) Rs4.7301.8 1.6%  
Earnings per share (Unadj.) Rs6.1-24.9 -24.5%  
Cash flow per share (Unadj.) Rs6.22.5 245.4%  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.7293.3 13.9%  
Shares outstanding (eoy) m267.0312.34 2,163.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.30.3 3,635.9%   
Avg P/E ratio x8.7-3.8 -230.8%  
P/CF ratio (eoy) x8.536.7 23.1%  
Price / Book Value ratio x1.30.3 408.5%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1391,154 1,225.5%   
No. of employees `000NA0.9 0.0%   
Total wages/salary Rs m207393 52.8%   
Avg. sales/employee Rs ThNM4,026.1-  
Avg. wages/employee Rs ThNM425.0-  
Avg. net profit/employee Rs ThNM-331.8-  
INCOME DATA
Net Sales Rs m1,2553,724 33.7%  
Other income Rs m37023 1,645.3%   
Total revenues Rs m1,6253,747 43.4%   
Gross profit Rs m111395 28.1%  
Depreciation Rs m38338 11.2%   
Interest Rs m2354 0.5%   
Profit before tax Rs m442-275 -160.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2432 75.8%   
Profit after tax Rs m1,630-307 -531.1%  
Gross profit margin %8.910.6 83.5%  
Effective tax rate %5.4-11.5 -47.2%   
Net profit margin %129.8-8.2 -1,575.6%  
BALANCE SHEET DATA
Current assets Rs m1,8672,638 70.8%   
Current liabilities Rs m5912,305 25.7%   
Net working cap to sales %101.68.9 1,136.7%  
Current ratio x3.21.1 275.9%  
Inventory Days Days94135 69.6%  
Debtors Days Days7446 158.7%  
Net fixed assets Rs m1,7914,871 36.8%   
Share capital Rs m534123 432.8%   
"Free" reserves Rs m10,3243,496 295.3%   
Net worth Rs m10,8583,619 300.0%   
Long term debt Rs m411,374 3.0%   
Total assets Rs m11,5917,509 154.4%  
Interest coverage x260.90.2 117,000.8%   
Debt to equity ratio x00.4 1.0%  
Sales to assets ratio x0.10.5 21.8%   
Return on assets %14.10.6 2,229.8%  
Return on equity %15.0-8.5 -177.0%  
Return on capital %15.21.6 960.1%  
Exports to sales %1.50-   
Imports to sales %21.013.9 151.3%   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263517 51.0%   
Fx inflow Rs m190-   
Fx outflow Rs m264517 51.1%   
Net fx Rs m-244-517 47.3%   
CASH FLOW
From Operations Rs m236514 45.8%  
From Investments Rs m-224-123 182.0%  
From Financial Activity Rs m-27-387 6.9%  
Net Cashflow Rs m-154 -352.4%  

Share Holding

Indian Promoters % 64.0 32.9 194.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.2 111.1%  
FIIs % 9.7 0.6 1,672.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 66.4 39.3%  
Shareholders   54,701 20,121 271.9%  
Pledged promoter(s) holding % 0.0 36.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  TTK HEALTHCARE  PROCTER & GAMBLE HEALTH  

Compare ALEMBIC LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 186 Points Higher; Energy and Power Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day on a positive note.

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, VENUS REMEDIES has posted a net profit of Rs 119 m (down 2301.8% YoY). Sales on the other hand came in at Rs 691 m (down 25.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Nov 19, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS